October 12, 2023 Comments Off on New patent for Janssen Biotech drug ERLEADA Posted in: Patent Added Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are ten patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugPa…
October 12, 2023 Comments Off on New patent for Astrazeneca drug LYNPARZA Posted in: Patent Added Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting…
The post New patent for Astrazeneca drug LYNPARZA appeared first…